Released Oct 29, 2018, after the close
10-Q filed Oct 29, 2018, 29 days after period end · 0001564590-18-025415
Q3 2018 · 10-Q
Revenue$111.71M$111.71M +6.1% vs Q3 2017+0.1% vs Q2 2018
Net Income-$1.21M-$1.21M N/M vs Q3 2017N/M vs Q2 2018
EPS Diluted-$0.07-$0.07 N/M vs Q3 2017N/M vs Q2 2018
Gross Profit$87,688,000+7.6%
Operating Income$3,907,000−56.8%
Operating Cash Flowderived$15,797,000+14.7%
Free Cash Flowderived$11,993,000+28.1%
Margins · derived
Gross margin78.5%+1.0 pt vs Q3 2017
Operating margin3.5%−5.1 pt vs Q3 2017
Net margin-1.1%−4.4 pt vs Q3 2017
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2018 | Q3 2017 | Q3 2016 | Q3 2015 |
|---|---|---|---|---|
| Revenue | $111.71M | $105.25M | $98.50M | $101.15M |
| Net Income | -$1.21M | $3.46M | $9.90M | -$1.37M |
| EPS Diluted | -$0.07 | $0.19 | $0.54 | -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR